Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Mariangela D'Onghia"'
Autor:
Alessia Manni, Antonio Iaffaldano, Giuseppe Lucisano, Mariangela D'Onghia, Domenico Maria Mezzapesa, Vincenzo Felica, Pietro Iaffaldano, Maria Trojano, Damiano Paolicelli
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Introduction: In relapsing Multiple Sclerosis (RMS) patients treated with disease modifying drugs (DMDs), few data are available regarding the biomarkers of treatment response. We aimed to assess the predictive value of lymphocyte count (LC) and Body
Externí odkaz:
https://doaj.org/article/54b0495983f247138d7789d79c943a87
Autor:
Damiano Paolicelli, Sergio Iannazzo, Laura Santoni, Antonio Iaffaldano, Valentina Di Lecce, Alessia Manni, Vito Lavolpe, Carla Tortorella, Mariangela D'Onghia, Vita Direnzo, Elisa Puma, Maria Trojano
Publikováno v:
PLoS ONE, Vol 11, Iss 7, p e0159214 (2016)
Relapsing Remitting Multiple Sclerosis (RRMS) patients treated with interferon beta (IFN beta) can develop neutralizing antibodies (NAbs) that reduce treatment efficacy. Several clinical studies explored the association of NAb+ status with increased
Externí odkaz:
https://doaj.org/article/b50de5d8f6044883899f27b134f50cbf
Autor:
Pietro Iaffaldano, Rosa Gemma Viterbo, Damiano Paolicelli, Guglielmo Lucchese, Emilio Portaccio, Benedetta Goretti, Vita Direnzo, Mariangela D'Onghia, Stefano Zoccolella, Maria Pia Amato, Maria Trojano
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35843 (2012)
Background and objectivesNatalizumab reduces the relapse rate and magnetic resonance imaging activity in patients with Relapsing-Remitting Multiple Sclerosis (RRMS). So far the influence of natalizumab on cognitive functions and fatigue in MS remains
Externí odkaz:
https://doaj.org/article/fd8907a15e1b4a6e9664f9498c11f071
Autor:
Stefano Zoccolella, Carla Tortorella, Pietro Iaffaldano, Vita Direnzo, Mariangela D'Onghia, Elena Luciannatelli, Damiano Paolicelli, Paolo Livrea, Maria Trojano
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40608 (2012)
BACKGROUND: Urate is a natural antioxidant and may prevent CNS tissue damage and the clinical manifestations of experimental autoimmune encephalitis. Results from clinical studies are conflicting and the contribution of urate to the pathogenesis of M
Externí odkaz:
https://doaj.org/article/b532d0c3c89c49ceb76e2a12a231e1ba
Autor:
Maria Trojano, Guglielmo Lucchese, Giusi Graziano, Bruce V Taylor, Steve Simpson, Vito Lepore, Francois Grand'maison, Pierre Duquette, Guillermo Izquierdo, Pierre Grammond, Maria Pia Amato, Roberto Bergamaschi, Giorgio Giuliani, Cavit Boz, Raymond Hupperts, Vincent Van Pesch, Jeannette Lechner-Scott, Edgardo Cristiano, Marcela Fiol, Celia Oreja-Guevara, Maria Laura Saladino, Freek Verheul, Mark Slee, Damiano Paolicelli, Carla Tortorella, Mariangela D'Onghia, Pietro Iaffaldano, Vita Direnzo, Helmut Butzkueven, MSBase Study Group and the New Zealand MS Prevalence Study Group
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e48078 (2012)
BACKGROUND: A female/male (F/M) ratio increase over time in multiple sclerosis (MS) patients was demonstrated in many countries around the world. So far, a direct comparison of sex ratio time-trends among MS populations from different geographical ar
Externí odkaz:
https://doaj.org/article/322d09d3e66a49c19af296677084346d
Autor:
Domenico Plantone, Claudia Dell’Aquila, Giuseppe Rinaldi, Eugenio Distaso, Mariangela D’Onghia, Antonio Giannini
Publikováno v:
Neurohospitalist
Trigeminal neuralgia associated with brainstem lesions is currently considered as a rare condition and only few patients have been reported so far in literature. Tohyama and colleagues recently proposed the nosological entity of trigeminal neuralgia
Autor:
Mariangela D’Onghia, Eugenio Distaso, Claudia Dell’Aquila, Giuseppe Rinaldi, Domenico Plantone, Antonio Giannini
Publikováno v:
Journal of the Neurological Sciences. 429:118121
Autor:
Vita Direnzo, Valentina Di Lecce, Damiano Paolicelli, Antonio Iaffaldano, Stefano Zoccolella, Maria Trojano, Alessia Manni, Carla Tortorella, Mariangela D'Onghia
Publikováno v:
The Journal of Clinical Pharmacology. 56:845-851
Delta-9-tetrahydrocannabinol (THC)/cannabidiol (CBD) oromucosal spray was approved as add-on therapy for spasticity in patients with multiple sclerosis (MS). We show our 40-week postmarketing experience regarding efficacy and safety of THC/CBD spray
Long-term cardiac safety and tolerability of fingolimod in multiple sclerosis: A postmarketing study
Autor:
Damiano Paolicelli, Stefano Zoccolella, Vita Direnzo, Carla Tortorella, Mariangela D'Onghia, Alessia Manni, Maria Trojano
Publikováno v:
The Journal of Clinical Pharmacology. 55:1131-1136
Fingolimod is the first oral disease-modifying therapy approved for multiple sclerosis (MS). The risks associated with the use of fingolimod include cardiovascular adverse events (AEs). First-dose observation (FDO) is required for all patients for at
Autor:
Maddalena Ruggieri, Damiano Paolicelli, Stefano Zoccolella, Maria Trojano, Mariangela D'Onghia, Franca Di Cuonzo, Claudio Gasperini, Carla Tortorella, Vita Direnzo, Mariangela Mastrapasqua
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 24(8)
Background: Brain atrophy is a known marker of irreversible tissue damage in multiple sclerosis (MS). Cerebrospinal fluid (CSF) osteopontin (OPN) and neurofilament light chain (NF-L) have been proposed as candidate surrogate markers of inflammatory a